Literature DB >> 26315572

Concise Review: Process Development Considerations for Cell Therapy.

Andrew Campbell1, Thomas Brieva2, Lior Raviv2, Jon Rowley2, Knut Niss2, Harvey Brandwein2, Steve Oh2, Ohad Karnieli2.   

Abstract

UNLABELLED: The development of robust and well-characterized methods of production of cell therapies has become increasingly important as therapies advance through clinical trials toward approval. A successful cell therapy will be a consistent, safe, and effective cell product, regardless of the cell type or application. Process development strategies can be developed to gain efficiency while maintaining or improving safety and quality profiles. This review presents an introduction to the process development challenges of cell therapies and describes some of the tools available to address production issues. This article will provide a summary of what should be considered to efficiently advance a cellular therapy from the research stage through clinical trials and finally toward commercialization. The identification of the basic questions that affect process development is summarized in the target product profile, and considerations for process optimization are discussed. The goal is to identify potential manufacturing concerns early in the process so they may be addressed effectively and thus increase the probability that a therapy will be successful. SIGNIFICANCE: The present study contributes to the field of cell therapy by providing a resource for those transitioning a potential therapy from the research stage to clinical and commercial applications. It provides the necessary steps that, when followed, can result in successful therapies from both a clinical and commercial perspective. ©AlphaMed Press.

Keywords:  Cellular therapy; Mesenchymal stem cells; Pluripotent stem cells; Process development; T cell

Mesh:

Year:  2015        PMID: 26315572      PMCID: PMC4572896          DOI: 10.5966/sctm.2014-0294

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  14 in total

Review 1.  Process analytical technology (PAT) for biopharmaceutical products.

Authors:  A S Rathore; R Bhambure; V Ghare
Journal:  Anal Bioanal Chem       Date:  2010-05-18       Impact factor: 4.142

Review 2.  Quality by design and process analytical technology for sterile products--where are we now?

Authors:  Bryan S Riley; Xuhong Li
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

3.  Statistical experimental design for bioprocess modeling and optimization analysis: repeated-measures method for dynamic biotechnology process.

Authors:  Kwang-Min Lee; David F Gilmore
Journal:  Appl Biochem Biotechnol       Date:  2006-11       Impact factor: 2.926

4.  Bioprocess optimization using design-of-experiments methodology.

Authors:  Carl-Fredrik Mandenius; Anders Brundin
Journal:  Biotechnol Prog       Date:  2008 Nov-Dec

Review 5.  Approaches to optimizing animal cell culture process: substrate metabolism regulation and protein expression improvement.

Authors:  Yuanxing Zhang
Journal:  Adv Biochem Eng Biotechnol       Date:  2009       Impact factor: 2.635

Review 6.  Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing.

Authors:  Shannon Eaker; Myriam Armant; Harvey Brandwein; Scott Burger; Andrew Campbell; Carmine Carpenito; Dominic Clarke; Timothy Fong; Ohad Karnieli; Knut Niss; Wouter Van't Hof; Ravenska Wagey
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

7.  Cell therapy industry: billion dollar global business with unlimited potential.

Authors:  Chris Mason; David A Brindley; Emily J Culme-Seymour; Natasha L Davie
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

8.  Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells.

Authors:  Jo'an Bardy; Allen K Chen; Yu Ming Lim; Selena Wu; Shunhui Wei; Han Weiping; Ken Chan; Shaul Reuveny; Steve K W Oh
Journal:  Tissue Eng Part C Methods       Date:  2012-09-04       Impact factor: 3.056

9.  Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor™. Part I. Effect of the cell density on the process.

Authors:  Marie-Françoise Clincke; Carin Mölleryd; Ye Zhang; Eva Lindskog; Kieron Walsh; Véronique Chotteau
Journal:  Biotechnol Prog       Date:  2013-05-21

10.  Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells.

Authors:  Tony Kwang-Poh Goh; Zhi-Yong Zhang; Allen Kuan-Liang Chen; Shaul Reuveny; Mahesh Choolani; Jerry Kok Yen Chan; Steve Kah-Weng Oh
Journal:  Biores Open Access       Date:  2013-04
View more
  26 in total

1.  A mechanistic roadmap for the clinical application of cardiac cell therapies.

Authors:  Eduardo Marbán
Journal:  Nat Biomed Eng       Date:  2018-06-11       Impact factor: 25.671

2.  VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH.

Authors:  Lucie Hartmann; Thomas Botzanowski; Mathieu Galibert; Magali Jullian; Eric Chabrol; Gabrielle Zeder-Lutz; Valérie Kugler; Johann Stojko; Jean-Marc Strub; Gilles Ferry; Lukasz Frankiewicz; Karine Puget; Renaud Wagner; Sarah Cianférani; Jean A Boutin
Journal:  Protein Sci       Date:  2019-08-29       Impact factor: 6.725

Review 3.  Pluripotent stem cells progressing to the clinic.

Authors:  Alan Trounson; Natalie D DeWitt
Journal:  Nat Rev Mol Cell Biol       Date:  2016-03       Impact factor: 94.444

Review 4.  Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy.

Authors:  Xue Yao; Sandro Matosevic
Journal:  BioDrugs       Date:  2021-08-24       Impact factor: 5.807

Review 5.  Promises and challenges of adoptive T-cell therapies for solid tumours.

Authors:  Matteo Morotti; Ashwag Albukhari; Abdulkhaliq Alsaadi; Mara Artibani; James D Brenton; Stuart M Curbishley; Tao Dong; Michael L Dustin; Zhiyuan Hu; Nicholas McGranahan; Martin L Miller; Laura Santana-Gonzalez; Leonard W Seymour; Tingyan Shi; Peter Van Loo; Christopher Yau; Helen White; Nina Wietek; David N Church; David C Wedge; Ahmed A Ahmed
Journal:  Br J Cancer       Date:  2021-03-29       Impact factor: 7.640

Review 6.  Advances in Manufacturing Cardiomyocytes from Human Pluripotent Stem Cells.

Authors:  Martha E Floy; Fathima Shabnam; Aaron D Simmons; Vijesh J Bhute; Gyuhyung Jin; Will A Friedrich; Alexandra B Steinberg; Sean P Palecek
Journal:  Annu Rev Chem Biomol Eng       Date:  2022-03-23       Impact factor: 9.700

Review 7.  Bioprocess microfluidics: applying microfluidic devices for bioprocessing.

Authors:  Marco Pc Marques; Nicolas Szita
Journal:  Curr Opin Chem Eng       Date:  2017-11       Impact factor: 5.163

Review 8.  Regenerative Medicine Build-Out.

Authors:  Andre Terzic; Michael A Pfenning; Gregory J Gores; C Michel Harper
Journal:  Stem Cells Transl Med       Date:  2015-11-04       Impact factor: 6.940

Review 9.  Clinical manufacturing of CAR T cells: foundation of a promising therapy.

Authors:  Xiuyan Wang; Isabelle Rivière
Journal:  Mol Ther Oncolytics       Date:  2016-06-15       Impact factor: 7.200

Review 10.  Climbing the mountain: experimental design for the efficient optimization of stem cell bioprocessing.

Authors:  Derek Toms; Rob Deardon; Mark Ungrin
Journal:  J Biol Eng       Date:  2017-12-04       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.